HealthCor Management as of Dec. 31, 2014
Portfolio Holdings for HealthCor Management
HealthCor Management holds 48 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mallinckrodt Pub | 7.3 | $131M | 1.3M | 99.03 | |
| Gilead Sciences (GILD) | 6.6 | $118M | 1.3M | 94.26 | |
| Pfizer (PFE) | 6.5 | $116M | 3.7M | 31.15 | |
| Valeant Pharmaceuticals Int | 5.2 | $93M | 650k | 143.11 | |
| Agilent Technologies Inc C ommon (A) | 4.7 | $84M | 2.0M | 40.94 | |
| Zimmer Holdings (ZBH) | 4.2 | $75M | 664k | 113.42 | |
| Horizon Pharma | 4.0 | $72M | 5.6M | 12.89 | |
| Keysight Technologies (KEYS) | 3.9 | $69M | 2.0M | 33.77 | |
| Illumina (ILMN) | 3.6 | $65M | 350k | 184.58 | |
| Salix Pharmaceuticals | 3.4 | $60M | 525k | 114.94 | |
| Laboratory Corp. of America Holdings | 3.3 | $59M | 550k | 107.90 | |
| Medivation | 3.2 | $57M | 575k | 99.61 | |
| Universal Health Services (UHS) | 2.8 | $50M | 450k | 111.26 | |
| Thermo Fisher Scientific (TMO) | 2.8 | $50M | 400k | 125.29 | |
| Omnicare | 2.7 | $49M | 675k | 72.93 | |
| WebMD Health | 2.7 | $48M | 1.2M | 39.55 | |
| Boston Scientific Corporation (BSX) | 2.6 | $46M | 3.5M | 13.25 | |
| Halyard Health | 2.4 | $43M | 951k | 45.47 | |
| Intuitive Surgical (ISRG) | 2.3 | $41M | 77k | 528.94 | |
| Mylan | 2.2 | $39M | 699k | 56.37 | |
| Tesaro | 2.2 | $39M | 1.1M | 37.19 | |
| Danaher Corporation (DHR) | 2.2 | $39M | 453k | 85.71 | |
| McKesson Corporation (MCK) | 2.0 | $37M | 176k | 207.58 | |
| NuVasive | 2.0 | $35M | 750k | 47.16 | |
| Health Care SPDR (XLV) | 1.9 | $34M | 500k | 68.38 | |
| Cardinal Health (CAH) | 1.7 | $31M | 385k | 80.73 | |
| Albany Molecular Research | 1.4 | $26M | 1.6M | 16.28 | |
| Alexion Pharmaceuticals | 1.3 | $24M | 127k | 185.03 | |
| Zoetis Inc Cl A (ZTS) | 1.2 | $22M | 513k | 43.03 | |
| Celgene Corporation | 1.1 | $20M | 182k | 111.86 | |
| Brookdale Senior Living (BKD) | 1.1 | $20M | 554k | 36.67 | |
| Versartis | 1.1 | $20M | 875k | 22.45 | |
| Teva Pharmaceutical Industries (TEVA) | 0.9 | $16M | 284k | 57.51 | |
| Pacira Pharmaceuticals (PCRX) | 0.6 | $11M | 125k | 88.66 | |
| Akebia Therapeutics (AKBA) | 0.6 | $9.8M | 845k | 11.64 | |
| Varian Medical Systems | 0.5 | $8.7M | 100k | 86.51 | |
| Derma Sciences | 0.5 | $8.6M | 920k | 9.31 | |
| Novavax | 0.2 | $3.9M | 650k | 5.93 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $3.8M | 224k | 16.89 | |
| Idera Pharmaceuticals | 0.2 | $3.6M | 808k | 4.41 | |
| Kythera Biopharmaceuticals I | 0.2 | $3.2M | 92k | 34.68 | |
| Celldex Therapeutics | 0.2 | $3.0M | 164k | 18.25 | |
| Keryx Biopharmaceuticals | 0.1 | $2.5M | 178k | 14.15 | |
| Syneron Medical Ltd ord | 0.1 | $2.5M | 263k | 9.33 | |
| XOMA CORP Common equity shares | 0.1 | $1.6M | 450k | 3.59 | |
| Achillion Pharmaceuticals | 0.1 | $1.2M | 100k | 12.25 | |
| Bellicum Pharma | 0.1 | $935k | 41k | 23.04 | |
| Cempra | 0.0 | $268k | 11k | 23.49 |
